(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Ect2 targets RhoA and Citron kinase to the cleavage furrow. (A) HeLa S3 cells were treated for 36 hours with control (GL2) or Ect2 siRNAs and the myc-Ect21-333-expressing cell line was induced for 36 hours with tetracycline. After fixation and permeabilization with 10% TCA and Triton X-100, siRNA-treated cells (upper and middle panels) were stained with anti-Ect2 (left, red) and anti-RhoA (middle, green) antibodies. The stable cell line (lower panel) was stained with anti-myc 9E10 (left, green) and anti-RhoA (middle, red) antibodies. Merged images are shown on the right with DNA in blue. (B) Cells were fixed with paraformaldehyde containing Triton X-100 and stained with anti-Citron kinase antibodies. Merged pictures are shown on the right with Ect2 and myc, respectively, in green, Citron kinase in red and DNA in blue. Bars, 10 µm.